Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Huffman

Showing results (1-10 of 325) with videos related to

Pageof 33
Sort By:
Current Problems in Cardiology|December 3, 2014
Cardiovascular health in low- and middle-income countriesMark D Huffman
Circulation|March 14, 2012
Association or causation of sugar-sweetened beverages and coronary heart disease: recalling Sir Austin Bradford HillMark D Huffman
BMJ (Clinical Research Ed.)|May 29, 2014
Fixed dose combinations of cardiovascular drugsMark D Huffman
Plos Medicine|August 12, 2015
The Polypill: From Promise to PragmatismMark D Huffman
JAMA Cardiology|October 21, 2016
Evaluating and Improving the Cardiovascular Drug Supply for Better Global HealthMark D Huffman
JAMA Cardiology|April 12, 2018
Maturing Methods for Cardiovascular Disease and Stroke Surveillance in the United StatesMark D Huffman
Journal of the American College of Cardiology|February 25, 2014
Polypills: essential medicines for cardiovascular disease secondary prevention?Mark D Huffman, Salim Yusuf
Heart Asia|May 5, 2017
Challenges and opportunities in accessing trial data: an example from statin primary prevention trialsGenevieve Umeh, Mark D Huffman
The National Medical Journal of India|January 22, 2011
Heart failure: epidemiology and prevention in IndiaMark D Huffman, Dorairaj Prabhakaran
Global Heart|March 4, 2024
Inclusion of Polypills for Prevention of Cardiovascular Disease in the 23rd World Health Organization Model List of Essential Medicines: A Significant Step Towards Reducing Global Cardiovascular Morbidity and MortalityAnubha Agarwal, Mark D Huffman
Pageof 33

Showing results (1-10 of 325) with videos related to

Sort By:
Pageof 33
Current Problems in Cardiology|December 3, 2014
Cardiovascular health in low- and middle-income countriesMark D Huffman
Circulation|March 14, 2012
Association or causation of sugar-sweetened beverages and coronary heart disease: recalling Sir Austin Bradford HillMark D Huffman
BMJ (Clinical Research Ed.)|May 29, 2014
Fixed dose combinations of cardiovascular drugsMark D Huffman
Plos Medicine|August 12, 2015
The Polypill: From Promise to PragmatismMark D Huffman
JAMA Cardiology|October 21, 2016
Evaluating and Improving the Cardiovascular Drug Supply for Better Global HealthMark D Huffman
JAMA Cardiology|April 12, 2018
Maturing Methods for Cardiovascular Disease and Stroke Surveillance in the United StatesMark D Huffman
Journal of the American College of Cardiology|February 25, 2014
Polypills: essential medicines for cardiovascular disease secondary prevention?Mark D Huffman, Salim Yusuf
Heart Asia|May 5, 2017
Challenges and opportunities in accessing trial data: an example from statin primary prevention trialsGenevieve Umeh, Mark D Huffman
The National Medical Journal of India|January 22, 2011
Heart failure: epidemiology and prevention in IndiaMark D Huffman, Dorairaj Prabhakaran
Global Heart|March 4, 2024
Inclusion of Polypills for Prevention of Cardiovascular Disease in the 23rd World Health Organization Model List of Essential Medicines: A Significant Step Towards Reducing Global Cardiovascular Morbidity and MortalityAnubha Agarwal, Mark D Huffman
Pageof 33